State Ledger
Company profile

Moleculin Biotech, Inc. CIK 1659617

Ticker
MBRX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Houston, TX 77007
Fiscal year end
2025 (FY)
Market Data
Close
$0.42
Change
-$0.02
Change %
-4.92%
Volume
376

MBRX · trading date Oct 13, 2026 · previous close $0.44 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$0
Net income
-$33.56M
Total assets
$22.13M
Total liabilities
$7.12M
Stockholders' equity
$15.01M
Cash & equivalents
$8.88M
Operating income
-$25.10M
Operating cash flow
-$22.74M
Capital expenditures
$0

Fiscal year 2025, via 10-K filed 2026-03-18. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$22.74M
Free cash flow margin
—
Liabilities / assets
32.2%
Equity / assets
67.8%
CapEx / revenue
—
Operating cash flow / net income
0.68×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $0 -$33.56M $22.13M $7.12M $15.01M
2024 $0 -$26.05M $16.93M $5.72M $11.21M
2023 $0 -$29.77M $38.22M $12.14M $30.93M
2022 $0 -$29.03M $57.42M $5.23M $52.19M
2021 $0 -$15.89M $84.09M $5.10M $78.99M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-18
Financials filed via
Form 10-K
filed 2026-03-18

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Houston, TX 77007
5300 MEMORIAL DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:57 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies